Effects of tetrandrine and fangchinoline on human platelet aggregation and thromboxane B2 formation

被引:24
|
作者
Kim, HS
Zhang, YH
Fang, LH
Yun, YP
Lee, HK
机构
[1] Chungbuk Natl Univ, Coll Pharm, Dept Pharmacol, Kaeshin Dong 361763, Cheongju, South Korea
[2] Chungbuk Natl Univ, Coll Med, Dept Pharmacol, Kaeshin Dong 361763, Cheongju, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Nat Prod Biosynth Res Unit, Taejon 305600, South Korea
关键词
fangochinoline; PAF-receptor binding; platelet aggregation; tetrandrine; thromboxane B-2;
D O I
10.1016/S0378-8741(98)00237-2
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Tetrandrine (TET) and fangchinoline (FAN) are two major components of the radix of Stephania tetrandra. The effects of TET and FAN on human platelet aggregation and formation of thromboxane (TX) B-2, a stable metabolite of TXA(2), were examined in the aspect of platelet aggregation. TET and FAN inhibited platelet-activating factor (PAF)-induced human platelet aggregation. IC50 values for TET and FAN were 28.6 +/- 3.24 mu M and 21.7 +/- 2.61 mu M, respectively. In the PAF-receptor binding assay, neither TET nor FAN showed any inhibitory effects on the specific bindings of PAF to its receptor. TET and FAN also inhibited PAF-, thrombin-: and arachidonic acid-induced thromboxane B-2 formation in human washed platelet. These results indicate that TET and FAN inhibit the platelet aggregation by interfering with the intracellular messengers system, but not by inhibiting the binding of PAF to PAF-receptor on the platelet membrane directly, and the suppression of TXA(2) formation by TET and FAN may be responsible for their inhibitory activities on the platelet aggregation and further on the thrombosis. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 50 条
  • [11] YHD & EYHD SUPPRESSES PLATELET ACTIVATION AND THROMBUS FORMATION BY REDUCING THROMBOXANE B2
    Wu, H., Sr.
    CARDIOLOGY, 2018, 140 : 411 - 411
  • [12] THROMBOXANE B2 PRODUCTION DURING AGGREGATION OF HUMAN-PLATELETS BY ADP AND COLLAGEN
    DALEY, WE
    SMITH, JB
    JUBIZ, W
    CLINICAL RESEARCH, 1980, 28 (01): : A47 - A47
  • [13] Comparison of the inhibitory of nimesulide and ASA on human platelet aggregation, tromboxano B2 formation and bleeding time
    Araujo, LCL
    Mattos-Filho, TR
    Donato, JL
    De Nucci, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R287 - R287
  • [14] THROMBOXANE B2 AND FIBRINOPEPTIDE A LEVELS IN PLATELET CONSUMPTION AND THROMBOSIS
    DAVIES, GC
    MOWSCHENSON, PM
    SALZMAN, EW
    SURGICAL FORUM, 1978, 29 : 471 - 472
  • [15] EMBRYOPATHIC EFFECTS OF THROMBOXANE B2 IN THE CHICK
    GILANI, SH
    PERSAUD, TVN
    PROSTAGLANDINS AND MEDICINE, 1981, 6 (06): : 627 - 631
  • [16] EFFECTS OF TRILOBINE ON PLATELET-AGGREGATION, THROMBOXANE A2, AND PROSTACYCLIN FORMATION IN RATS
    TAN, JQ
    CHU, ZX
    SHEN, FM
    LIANG, HQ
    CHEN, HS
    ACTA PHARMACOLOGICA SINICA, 1991, 12 (04): : 375 - &
  • [17] INVITRO EFFECTS OF ACETAMINOPHEN AND ITS ANALOGS ON HUMAN-PLATELET AGGREGATION AND THROMBOXANE-B2 SYNTHESIS
    SHORR, RI
    KAO, KJ
    PIZZO, SV
    RAUCKMAN, EJ
    ROSEN, GM
    THROMBOSIS RESEARCH, 1985, 38 (01) : 33 - 43
  • [18] THE EFFECTS OF CYCLOSPORINE ON HUMAN-PLATELET AGGREGATION AND THROMBOXANE RELEASE
    JORKASKY, DK
    FISHER, CA
    STAHL, RF
    ADDONIZIO, VP
    GLICKMAN, JD
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 948 - 949
  • [19] INVITRO EFFECTS OF PICOTAMIDE ON HUMAN PLATELET-AGGREGATION, THE RELEASE REACTION AND THROMBOXANE-B2 PRODUCTION
    CATTANEO, M
    TENCONI, PM
    LECCHI, A
    MANNUCCI, PM
    THROMBOSIS RESEARCH, 1991, 62 (06) : 717 - 724
  • [20] DIFFERENT EFFECTS OF NISOLDIPINE, NIFEDIPINE AND NITRENDIPINE ON HUMAN-PLATELET AGGREGATION AND THROMBOXANE FORMATION INVITRO
    LATTA, G
    SCHROR, K
    JOURNAL DE PHARMACOLOGIE, 1986, 17 (02) : 189 - 189